Erlotinib Hydrochloride Tablet, Film Coated
Product Images NDC 72205-080

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Erlotinib Hydrochloride (NDC 72205-080). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

100-mg-carton-label (100 mg Carton Label)

100-mg-carton-label (100 mg Carton Label)
The text is not readable and appears to be garbled output. Therefore, the description cannot be generated.*
FDA Label Image

100-mg-cntr-label (100 mg Cntr Label)

100-mg-cntr-label (100 mg Cntr Label)
This text appears to be a medication label that provides information about the medication name, dosage, storage, manufacturers, and distributors. The medication is called "ficosted tablet" and contains 100mg of el with the Fe base. The label provides guidance on the usual dosage and storage temperature. It is produced by MSN Laboratories Private Limited in India and distributed by Novadoz Pharmaceuticals in New Jersey. The label also cautions users to keep the medication out of the reach of children.*
FDA Label Image

150-mg-carton-label (150 mg Carton Label)

150-mg-carton-label (150 mg Carton Label)
This is a prescription drug called Erlotinib Tablets, manufactured by MSN Laboratories in India and distributed in the US by Novadoz Pharmaceuticals LLC. The tablets come in a bottle of 30 and contain 150mg of Erlotinib Hydrochloride. The usual dosage and storage instructions are provided in the enclosed package insert. This medicine is only available with a prescription and should be kept out of the reach of children.*
FDA Label Image

150-mg-cntr-label (150 mg Cntr Label)

150-mg-cntr-label (150 mg Cntr Label)
FDA Label Image

25-mg-carton-label (25 mg Carton Label)

25-mg-carton-label (25 mg Carton Label)
FDA Label Image

25-mg-cntr-label (25 mg Cntr Label)

25-mg-cntr-label (25 mg Cntr Label)
FDA Label Image

Srt (Erlotinib Structure)

Srt (Erlotinib Structure)
HCI stands for Human-Computer Interaction, which refers to the study and design of interfaces between people and technology. It encompasses the process of designing user interfaces, evaluating the usability of systems, and studying the behavior of users interacting with technology. HCI is a multidisciplinary field that draws on expertise from computer science, psychology, design, engineering, and other areas to create technology that is effective, efficient, and enjoyable to use.*
FDA Label Image

Fig-1 (Figure 1)

Fig-1 (Figure 1)
FDA Label Image

Fig-2 (Figure 2)

Fig-2 (Figure 2)
This appears to be a survival probability chart, showing the overall survival rate in months for two different treatment groups (placebo and Erlotinib), as well as the number of patients at risk for each month. It is unclear what condition or disease the treatments are being used for.*
FDA Label Image

Fig-3 (Figure 3)

Fig-3 (Figure 3)
FDA Label Image

Fig-4 (Figure 4)

Fig-4 (Figure 4)
This is a graph or a chart that represents the survival probability of patients who received either placebo or erlotinib for overall survival (in months). The graph shows the number of patients at risk for both treatments at different time intervals (in months) from 0 to 39. The has also captured some of the numerical values in the graph.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.